Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.47 | 5e-20 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-14 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-13 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |